Patent · US Active

Compositions and methods for inhibiting expression of the LECT2 gene

US11987792B2 · kind B2 · utility

0Cited by
3References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 15, 2019
Grant dateMay 21, 2024
Priority date
Expiry dateJul 17, 2040

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2320/35
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention relates to double-stranded ribonucleic acid (dsRNA) compositions targeting the LECT2 gene, and methods of using such dsRNA compositions to alter (e.g., inhibit) expression of LECT2.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.